FDA issued a Warning Letter to Beijing Taiyang Pharmaceutical Industry Co Ltd on 10/19/2016 as a result of this inspection.
483 Beijing Taiyang Pharmaceutical Industry Nov 2015

483 Beijing Taiyang Pharmaceutical Industry Nov 2015

Rafael Arroyo FDA, Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Beijing Taiyang Pharmaceutical Industry - Chaoyang, China facility and issued 7 inspectional observations (via FDA 483) on 19 Nov 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 7
  • Inspection end: 19 Nov 2015
  • Location: Chaoyang, China
  • FEI: 3003828267
Add To Cart